MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherenc...( MEMOTEXT(R) Personalized Adherence ...),Health

    MEMOTEXT(R) Personalized Adherence Interventions Incorporated into
    First-of-its-Kind Study Funded by Microsoft HealthVault Be Well Fund

BETHESDA, MD, Jan. 13 /PRNewswire/ - MEMOTEXT announced today that Johns Hopkins University's Wilmer Eye Institute will conduct a clinical trial on patient adherence and clinical outcomes for people with glaucoma using technology developed by MEMOTEXT. The clinical trial, titled "The Impact of Automated Dosing Reminders on Medication Adherence Using HealthVault," is funded by a Microsoft(R) HealthVault(TM) Be Well Fund grant. The 14-month study, to be led by Michael V. Boland, M.D., Ph.D. of the Wilmer Eye Institute, will recruit 500 patients and use telephone calls and text messages in an effort to improve patient outcomes by improving medication adherence.

"We believe this new interface will significantly improve medication adherence in patients with glaucoma," says Amos Adler, President of MEMOTEXT. "It is an honor to collaborate on this special grant, and we are confident this trial will demonstrate that MEMOTEXT's technology-driven adherence solutions can make a significant difference in the lives of patients managing various conditions."

Studies have shown that medication non-adherence costs North America more than $100 billion and 125,000 lives every year. Medication non-adherence impacts all levels of health management, including treatment effectiveness and unnecessary hospitalizations, and almost six percent of all hospital admissions are due to failed patient adherence. Research also indicates that 70% of prescriptions are never consumed and 20% of all new drug prescriptions are never filled for the first time - with adherence rates as low as 10-20% for some disease states.

Approximately 40% of glaucoma patients have difficulty taking their eye drops on a regular basis, resulting in poor care despite an appropriate physician diagnosis and treatment
'/>"/>